These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 23722646

  • 1. Chloroquine blocks the autophagic process in cisplatin-resistant osteosarcoma cells by regulating the expression of p62/SQSTM1.
    Shen C, Wang W, Tao L, Liu B, Yang Z, Tao H.
    Int J Mol Med; 2013 Aug; 32(2):448-56. PubMed ID: 23722646
    [Abstract] [Full Text] [Related]

  • 2. miR-375 targeting autophagy-related 2B (ATG2B) suppresses autophagy and tumorigenesis in cisplatin-resistant osteosarcoma cells.
    Gao S, Wang K, Wang X.
    Neoplasma; 2020 Jul; 67(4):724-734. PubMed ID: 32726125
    [Abstract] [Full Text] [Related]

  • 3. p62/SQSTM1 involved in cisplatin resistance in human ovarian cancer cells by clearing ubiquitinated proteins.
    Yu H, Su J, Xu Y, Kang J, Li H, Zhang L, Yi H, Xiang X, Liu F, Sun L.
    Eur J Cancer; 2011 Jul; 47(10):1585-94. PubMed ID: 21371883
    [Abstract] [Full Text] [Related]

  • 4. Chloroquine enhances the efficacy of cisplatin by suppressing autophagy in human adrenocortical carcinoma treatment.
    Qin L, Xu T, Xia L, Wang X, Zhang X, Zhang X, Zhu Z, Zhong S, Wang C, Shen Z.
    Drug Des Devel Ther; 2016 Jul; 10():1035-45. PubMed ID: 27022243
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Interference with HMGB1 increases the sensitivity to chemotherapy drugs by inhibiting HMGB1-mediated cell autophagy and inducing cell apoptosis.
    Zhang R, Li Y, Wang Z, Chen L, Dong X, Nie X.
    Tumour Biol; 2015 Nov; 36(11):8585-92. PubMed ID: 26040768
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of beclin1 affects the chemotherapeutic sensitivity of osteosarcoma.
    Wu W, Li W, Zhou Y, Zhang C.
    Int J Clin Exp Pathol; 2014 Nov; 7(10):7114-22. PubMed ID: 25400807
    [Abstract] [Full Text] [Related]

  • 8. Immunomodulatory proteins FIP-gts and chloroquine induce caspase-independent cell death via autophagy for resensitizing cisplatin-resistant urothelial cancer cells.
    Hsin IL, Wang SC, Li JR, Ciou TC, Wu CH, Wu HM, Ko JL.
    Phytomedicine; 2016 Dec 01; 23(13):1566-1573. PubMed ID: 27823620
    [Abstract] [Full Text] [Related]

  • 9. p62/SQSTM1 is involved in cisplatin resistance in human ovarian cancer cells via the Keap1-Nrf2-ARE system.
    Xia M, Yu H, Gu S, Xu Y, Su J, Li H, Kang J, Cui M.
    Int J Oncol; 2014 Dec 01; 45(6):2341-8. PubMed ID: 25269472
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of p62/SQSTM1 sensitizes small-cell lung cancer cells to cisplatin-induced cytotoxicity by targeting NEDD9 expression.
    Xu L, Xu F, Kong Q, Yang T, Tan D, Zhang X, Li N, Zhao S, Zhao J, Li M.
    Mol Carcinog; 2020 Aug 01; 59(8):967-979. PubMed ID: 32424979
    [Abstract] [Full Text] [Related]

  • 11. KLF4-SQSTM1/p62-associated prosurvival autophagy contributes to carfilzomib resistance in multiple myeloma models.
    Riz I, Hawley TS, Hawley RG.
    Oncotarget; 2015 Jun 20; 6(17):14814-31. PubMed ID: 26109433
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Autophagic flux determines cell death and survival in response to Apo2L/TRAIL (dulanermin).
    Singh K, Sharma A, Mir MC, Drazba JA, Heston WD, Magi-Galluzzi C, Hansel D, Rubin BP, Klein EA, Almasan A.
    Mol Cancer; 2014 Mar 23; 13():70. PubMed ID: 24655592
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. MiR-100 up-regulation enhanced cell autophagy and apoptosis induced by cisplatin in osteosarcoma by targeting mTOR.
    Yu Z, Li N, Jiang K, Zhang N, Yao LL.
    Eur Rev Med Pharmacol Sci; 2018 Sep 23; 22(18):5867-5873. PubMed ID: 30280766
    [Abstract] [Full Text] [Related]

  • 17. Decreased Level of Klotho Contributes to Drug Resistance in Lung Cancer Cells: Involving in Klotho-Mediated Cell Autophagy.
    Chen T, Ren H, Thakur A, Yang T, Li Y, Zhang S, Wang T, Chen M.
    DNA Cell Biol; 2016 Dec 23; 35(12):751-757. PubMed ID: 27661766
    [Abstract] [Full Text] [Related]

  • 18. ABT-737 potentiates cisplatin-induced apoptosis in human osteosarcoma cells via the mitochondrial apoptotic pathway.
    Zhang F, Yu X, Liu X, Zhou T, Nie T, Cheng M, Liu H, Dai M, Zhang B.
    Oncol Rep; 2017 Oct 23; 38(4):2301-2308. PubMed ID: 28849162
    [Abstract] [Full Text] [Related]

  • 19. Anticancer potential of TUG1 knockdown in cisplatin-resistant osteosarcoma through inhibition of MET/Akt signalling.
    Zhou Q, Hu T, Xu Y.
    J Drug Target; 2020 Feb 23; 28(2):204-211. PubMed ID: 31305159
    [Abstract] [Full Text] [Related]

  • 20. Acquired cisplatin resistance in human lung adenocarcinoma cells is associated with enhanced autophagy.
    Ren JH, He WS, Nong L, Zhu QY, Hu K, Zhang RG, Huang LL, Zhu F, Wu G.
    Cancer Biother Radiopharm; 2010 Feb 23; 25(1):75-80. PubMed ID: 20187799
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.